Press Release

PhRMA Statement on Former Congressman Bob Franks

PhRMA April 30, 2013

Washington, D.C. (April 12, 2010) – Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO Billy Tauzin today released the following statement:

“It is with great sadness that we received the news of Bob’s passing. The state of New Jersey, the medical research community and patients across America have lost a skilled and compassionate champion.

“As a former colleague in the U.S. House of Representatives and, in recent years, a fellow advocate for the pharmaceutical research and biotechnology sector, I long admired Bob for his work ethic, his values and his unshakable good humor. PhRMA and its member companies offer our profound sympathy and prayers to Bob’s family.”

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA companies are leading the way in the search for new cures. PhRMA members alone invested an estimated $50.3 billion in 2008 in discovering and developing new medicines. Industry-wide research and investment reached a record $65.2 billion in 2008.

PhRMA Internet Address:

For information on stories of hope and survival, visit:

For information on how innovative medicines save lives, visit:

For information on the Partnership for Prescription Assistance, visit:

For more information on public health emergencies, visit:

For information on the danger of imported drugs, visit: